Manufacturer
Gland Pharma Limited
Contents
Rocuronium Bromide 50mg/5ml
Indication
Facilitate endotracheal intubation, Facilitate mechanical ventilation in intensive care, Muscle relaxant in general anaesthesia
Instruction
Adult: IV Facilitate endotracheal intubation; Muscle relaxant in general anaesth; Facilitate mechanical ventilation in intensive care Initial: 0.6 mg/kg by inj. Maintenance: 0.15 mg/kg by inj or by infusion at 0.3-0.6 mg/kg/hr.
Drug interaction
Increased effect w/ halogenated volatile anaesth (e.g. enflurane, isoflurane), antibiotics (e.g. aminoglycoside, lincosamide and polypeptide antibiotics, acylamino-penicillin antibiotics), diuretics, quinidine, quinine, Mg and lithium salts, Ca channel blockers, local anaesth, acute admin of phenytoin or β-blocking agents, corticosteroid (long-term use) and after intubation w/ suxamethonium. Decreased effect w/ Ca chloride and KCl, protease inhibitors (e.g. gabexate, ulinastatin), chronic admin of phenytoin or carbamazepine.
Malaysia
